Stemirna Funding: $188M Raised, Series C (2021)

Stemirna funding overview

Stemirna is based in Shanghai, China. Stemirna has raised $188M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in June 2021. The round record for Stemirna runs through 2021; nothing later has been disclosed. Investors on record include Sequoia Capital China, WuXi AppTec, OrbiMed, China Merchants Medical and Healthcare Industry Equity Fund, Greenwoods Investment, Advantech Capital and 5 others. 11 distinct backers are named across the disclosed rounds.

Stemirna at a glance

Total raised: $188M
Latest round: Series C
Latest round date: June 2021
Headquarters: Shanghai, China
Notable investors: Sequoia Capital China, WuXi AppTec, OrbiMed, China Merchants Medical and Healthcare Industry Equity Fund, Greenwoods Investment, Advantech Capital, Guoxin Guotong, Efund

Frequently asked about Stemirna funding

How much has Stemirna raised?: Stemirna has raised $188M in total disclosed funding across the rounds on record.
Who has invested in Stemirna?: Sequoia Capital China, WuXi AppTec, OrbiMed, China Merchants Medical and Healthcare Industry Equity Fund, Greenwoods Investment, Advantech Capital are named among the investors backing Stemirna.
What was the latest Stemirna funding round?: The most recent disclosed round is a Series C, announced in June 2021.
Where is Stemirna based?: Stemirna is based in Shanghai, China.
When did Stemirna last raise?: The last disclosed Stemirna round closed in June 2021 at Series C.

Stemirna totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.

Stemirna Funding: $188M Raised, Series C (2021)

Stemirna funding overview

Stemirna at a glance

Frequently asked about Stemirna funding

Companies related to Stemirna (35)

Browse related funding lists (6)